Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP3K7 | O43318 | 1/20 | 0.54 |
| ▸ | TAB1 | Q15750 | 1/20 | 0.54 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.47 |
| ▸ | TUBB | P07437 | 1/20 | 0.47 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.47 |
| ▸ | AR | P10275 | 1/20 | 0.47 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.47 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.47 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.47 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.47 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.47 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.47 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.47 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.47 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.47 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.47 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.47 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.47 |
| ▸ | S100A4 | P26447 | 1/20 | 0.44 |
| ▸ | CDYL2 | Q8N8U2 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4978768 | 1.00 | MAP3K7 (0.54) | MAP3K7TAB1TUBB4ATUBBTUBA3C | |
| SCHEMBL4978547 | 0.89 | MAP3K7 (0.64) | MAP3K7TAB1TUBB4ATUBBTUBA3C | |
| SCHEMBL4781796 | 0.89 | MAP3K7 (0.50) | MAP3K7TAB1CDYL2CDYLCDY1; CDY1B | |
| SCHEMBL14273456 | 0.89 | MAP3K7 (0.50) | MAP3K7TAB1CDYL2CDYLCDY1; CDY1B | |
| SCHEMBL4777407 | 0.89 | MAP3K7 (0.50) | MAP3K7TAB1CDYL2CDYLCDY1; CDY1B | |
| SCHEMBL14273455 | 0.89 | MAP3K7 (0.50) | MAP3K7TAB1CDYL2CDYLCDY1; CDY1B | |
| SCHEMBL4781798 | 0.89 | MAP3K7 (0.50) | MAP3K7TAB1CDYL2CDYLCDY1; CDY1B | |
| SCHEMBL4777410 | 0.89 | MAP3K7 (0.50) | MAP3K7TAB1CDYL2CDYLCDY1; CDY1B | |
| SCHEMBL4838997 | 0.85 | MAP3K7 (0.52) | MAP3K7TAB1TUBB4ATUBBTUBA3C | |
| SCHEMBL4986329 | 0.85 | TGM2 (0.53) | MAP3K7TAB1TGM2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080051463-A1 | ANTHRACENE COMPOUNDS AND THEIR USE FOR TREATING BENIGN AND MALIGNANT TUMOR DISORDERS | AETERNA ZENTARIS GMBH (DE) | 2008-02-28 | — | — | US | claimed |
| US-20080051463-A1 | ANTHRACENE COMPOUNDS AND THEIR USE FOR TREATING BENIGN AND MALIGNANT TUMOR DISORDERS | AETERNA ZENTARIS GMBH (DE) | 2008-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080051463-A1 | ANTHRACENE COMPOUNDS AND THEIR USE FOR TREATING BENIGN AND MALIGNANT TUMOR DISORDERS | TUBB1, TUBA1C, TUBB3 | MAP3K7 1090/4885TAB1 981/4885TUBB4A 11/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.